Board of Scientific Counselors, Coordinating Center for Infectious Diseases (CCID), 22607 [2010-9953]

Download as PDF Federal Register / Vol. 75, No. 82 / Thursday, April 29, 2010 / Notices Special Minority Initiatives, National Institutes of Health, HHS) Dated: April 23, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–9987 Filed 4–28–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Meetings mstockstill on DSKH9S0YB1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of meetings of the National Advisory Neurological Disorders and Stroke Council. The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Neurological Disorders and Stroke Council, Clinical Trials Subcommittee. Date: May 26–27, 2010. Closed: May 26, 2010, 6:30 p.m. to 8 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Open: May 27, 2010, 8 a.m. to 9:30 a.m. Agenda: To discuss clinical trials policy. Place: National Institutes of Health, Building 31, 31 Center Drive, 6th Floor, Conference Room 10, Bethesda, MD 20892. Contact Person: Petra Kaufmann, MD, Director, Office of Clinical Research, NINDS, National Institutes of Health, Neuroscience Center, Room 2216, 6001 Executive Blvd. (301) 496–9135. Kaufmanp2@ninds.nih.gov. Name of Committee: National Advisory Neurological Disorders and Stroke Council, Basic and Preclinical Programs Subcommittee. VerDate Mar<15>2010 16:19 Apr 28, 2010 Jkt 220001 Date: May 27, 2010. Time: 8 a.m. to 9:30 a.m. Agenda: To discuss basic and preclinical policy. Place: National Institutes of Health, Building 31, 31 Center Drive, 6th Floor, Conference Room 7, Bethesda, MD 20892. Contact Person: William D. Matthew, PhD, Director, Office of Translational Research, NINDS, National Institutes of Health, Neuroscience Center, Room 2137, 6001 Executive Blvd. (301) 496–1779. Bill.Matthew@nih.gov. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: https:// www.ninds.nih.gov, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: April 23, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–9986 Filed 4–28–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, Coordinating Center for Infectious Diseases (CCID) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the cancellation of the May 2010 meeting of the aforementioned board. Due to unanticipated circumstances and scheduling conflicts, the board does not have the quorum required to convene. Contact Person for More Information: Leola Mitchell, Office of the Director, CCID, CDC, 1600 Clifton Road, NE., Mailstop K–74, Atlanta, Georgia 30333, e-mail fvp9@cdc.gov, telephone (770) 488–8366. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 22607 meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 21 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2010–9953 Filed 4–28–10; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), and pursuant to the requirements of 42 CFR 83.15(a), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Board Public Meeting Times and Dates (All times are Eastern Time) 8:15 a.m.–4:30 p.m., May 19, 2010. 8:15 a.m.–6 p.m., May 20, 2010. 8:15 a.m.–12 p.m., May 21, 2010. Public Comment Times and Dates (All times are Eastern Time) 4:30 p.m.–6 p.m.,* May 19, 2010. 6 p.m.–7:30 p.m.,* May 20, 2010. *Please note that the public comment periods may end before the times indicated, following the last call for comments. Members of the public who wish to provide public comment should plan to attend public comment sessions at the start times listed. Place: Crowne Plaza Hotel, 300 3rd Street, Niagara Falls, New York; Phone: 716–285– 3361; Fax: 716–285–3900. Audio Conference Call via FTS Conferencing. The USA toll free dial in number is 1–866–659–0537 with a pass code of 9933701. Status: Open to the public, limited only by the space available. The meeting space accommodates approximately 200 people. Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program (EEOICP) Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines which have been promulgated by the Department of Health and Human Services (HHS) as a final rule, advice on methods of dose reconstruction which have also been E:\FR\FM\29APN1.SGM 29APN1

Agencies

[Federal Register Volume 75, Number 82 (Thursday, April 29, 2010)]
[Notices]
[Page 22607]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-9953]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, Coordinating Center for 
Infectious Diseases (CCID)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the cancellation of the May 2010 meeting of 
the aforementioned board. Due to unanticipated circumstances and 
scheduling conflicts, the board does not have the quorum required to 
convene.
    Contact Person for More Information: Leola Mitchell, Office of the 
Director, CCID, CDC, 1600 Clifton Road, NE., Mailstop K-74, Atlanta, 
Georgia 30333, e-mail fvp9@cdc.gov, telephone (770) 488-8366.
    The Director, Management Analysis and Services Office has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: April 21 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2010-9953 Filed 4-28-10; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.